A former mortician has pitched a pay-to-play clinical trial that gives over-the-hill participants blood infusions from sprightly young donors.
Are you rich and obsessed with the inevitable decline of your aging body? Then boy, does Bill Faloon have an offer for you!
As “Scientific American” reported on Friday, the 63-year-old former mortician recently pitched an audience of wealthy baby boomers on his “young blood project,” a pay-to-play clinical trial that gives over-the-hill participants blood infusions from sprightly young donors.
The price? A cool $285,000. (That’s $277,000 more than California startup Ambrosia charged for the same service last year.)
The study promises participants a year of monthly blood infusions from young people who have been injected with a drug intended to stimulate their immune systems. Although there’s no real proof that this experimental treatment works, proponents like Faloon claim that it can reverse the physical effects of aging.
Faloon is promoting this work on behalf of a Boynton Beach, Fla., doctor named Dipnarine Maharaj, a hematologist and oncologist who caters to an affluent clientele. Maharaj claims that he has already gotten FDA approval for this trial, but wouldn’t submit the supporting paperwork to Scientific American.
Participants will simply have to put their trust — and their money — in the hands of Faloon and Maharaj, and buy into the Silicon Valley-led hype that a fresh blood IV is the new fountain of youth.
The donors, who will be between the ages of 18 and 35, will be compensated for their trouble. What does giving up a year’s worth of covetable young blood get you? Just $750.
There's a "text bomb" going around.
A devastating 'text bomb' that crashes Apple devices has been uncovered by researchers.
It works by sending iPhones, iPads and Macs into a frenzy thanks to a single character from a language used in India.
Opening a message containing the character is enough to crash iOS Springboard, the system app which manages the device's home screen.
Apple gadgets running iOS 11.2.5 or macOS, are susceptible to the bug, which disables access to iMessages.